Dupilumab Subcutaneous and EndaCof-PD
Determining the interaction of Dupilumab Subcutaneous and EndaCof-PD and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dupilumab
Brand name: Dupixent
Synonyms: Dupilumab
Generic Name: brompheniramine / dextromethorphan / guaifenesin / phenylephrine
Brand name: AccuHist PDX Syrup, Allanhist PDX Syrup, Bromhist-PDX, EndaCof-PD, Uni-Hist PDX Syrup
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dupilumab Subcutaneous-Endal CD Syrup
- Dupilumab Subcutaneous-Endocet
- Dupilumab Subcutaneous-Endocet 10/325
- Dupilumab Subcutaneous-Endocet 2.5/325
- Dupilumab Subcutaneous-Endocet 5/325
- Dupilumab Subcutaneous-Endocet 7.5/325
- EndaCof-PD-Dupixent
- EndaCof-PD-Duplex T Topical
- EndaCof-PD-Durachol
- EndaCof-PD-Duraclon
- EndaCof-PD-Duraclon injection
- EndaCof-PD-Duraflu